Guangzhou Sipaida Outdoor Products Co., Ltd. – Trademark Portfolio
Entity Type: 99
Guangzhou Sipaida Outdoor Products Co., Ltd. holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 25 (Clothing) — 4 filings in this category. The portfolio also extends into Class 18 (Leather Goods) across 2 Nice Classification classes. Currently, 6 trademarks are registered. Notable registered marks include XPETI, SKENARY, XPETI DUTY, and XPETI WORK. The owner is based in Guangzhou.
Room 302-6, Bldg. 1, No.1963,Huaguan Rd.
Xintang, Tianhe District
Guangzhou 510000 , CN
Showing of trademarks Trademarks
Trademark Classifications
Guangzhou Sipaida Outdoor Products Co., Ltd.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Leather and imitations of leather; animal skins, hides; trunks and travelling bags
Frequently Asked Questions
How many trademarks does Guangzhou Sipaida Outdoor Products Co., Ltd. have?
Guangzhou Sipaida Outdoor Products Co., Ltd. has 6 U.S. trademarks filed with the USPTO. Of these, 6 registered.
What trademark classes does Guangzhou Sipaida Outdoor Products Co., Ltd. file in?
Guangzhou Sipaida Outdoor Products Co., Ltd. files trademarks across 2 Nice Classification classes. The most active classes are Class 25 (Clothing), Class 18 (Leather Goods). Class 25 covers clothing, footwear, headgear.
What are Guangzhou Sipaida Outdoor Products Co., Ltd.'s most well-known trademarks?
Guangzhou Sipaida Outdoor Products Co., Ltd.'s registered trademark portfolio includes well-known marks such as XPETI, SKENARY, XPETI DUTY, and XPETI WORK. These are among 6 currently registered trademarks in the portfolio.
What is Guangzhou Sipaida Outdoor Products Co., Ltd.'s trademark registration success rate?
Guangzhou Sipaida Outdoor Products Co., Ltd. has a 100% trademark registration rate, with 6 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.